Evolutionary selection of pancreatic cancer cells leads to chemoresistance
May 22, 2019
Researchers at The University of Texas MD Anderson Cancer Center have shown how pretreatment clonal complexity in pancreatic tumor cells leads to chemotherapy resistance, findings that could lead to better-personalized and effective combination therapies.
Tumorigenesis is an evolutionary process. “A tumor is an ecosystem composed of different cell populations, and the fittest survive,” says Alessandro Carugo, Ph.D., research scientist...
